# A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)

> **NCT00092547** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 1781 (actual)

## Conditions studied

- Human
- Papillomavirus Infections

## Interventions

- **BIOLOGICAL:** V501
- **BIOLOGICAL:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00092547
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10-08
- **Primary completion:** 2005-11-03
- **Final completion:** 2015-06-01
- **Target enrollment:** 1781 (ACTUAL)
- **Last updated:** 2018-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092547, "A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)". Retrieved via MORVS 2026-10-13 from https://api.morvs.ai/clinical/NCT00092547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*